The human immunodeficiency virus associated dementia complex (ADC) follows progressive viral infection and immunosuppression in a significant proportion of infected individuals. The mechanisms for disease, in measure, revolve around viral infection and immune activation of brain mononuclear phagocytes (macrophages and microglia). Studies from our laboratory support distinctive role for each cell type in disease. This component of the program project grant will investigate indirect mechanisms of HIV neuropathogenesis utilizing age-matched human microglia and blood-derived monocytes to examine the neurotoxic responses elicited following immune activation and HIV-1 infection. The mechanisms for viral entry, the chemotactic factors that underlie monocyte penetration into brain and the elucidation of the biological and molecular events in which mononuclear phagocytes induce neural injury will be explored. The hypothesis being tested is that functional differences exist between the two phagocytic cell types and that microglial cells are a principle participant in HIV-1 associated neuropathological injury. The laboratory has now gained significant expertise together with other project responses, it utilizing molecular and biochemical approaches for identifying HIV-induced neurotoxins and in developing small animal model systems for ADC. Such experimental systems will be utilized in determining the precise role played by mononuclear phagocytes in ADC.
| Schutt, Charles R; Gendelman, Howard E; Mosley, R Lee (2018) Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease. Mol Neurodegener 13:26 |
| Sillman, Brady; Bade, Aditya N; Dash, Prasanta K et al. (2018) Creation of a long-acting nanoformulated dolutegravir. Nat Commun 9:443 |
| Thomas, Midhun B; Gnanadhas, Divya Prakash; Dash, Prasanta K et al. (2018) Modulating cellular autophagy for controlled antiretroviral drug release. Nanomedicine (Lond) 13:2139-2154 |
| McMillan, JoEllyn; Szlachetka, Adam; Slack, Lara et al. (2018) Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques. Antimicrob Agents Chemother 62: |
| Sillman, Brady; Woldstad, Christopher; Mcmillan, Joellyn et al. (2018) Neuropathogenesis of human immunodeficiency virus infection. Handb Clin Neurol 152:21-40 |
| Zhou, Tian; Su, Hang; Dash, Prasanta et al. (2018) Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles. Biomaterials 151:53-65 |
| Kevadiya, Bhavesh D; Ottemann, Brendan M; Thomas, Midhun Ben et al. (2018) Neurotheranostics as personalized medicines. Adv Drug Deliv Rev : |
| McMillan, JoEllyn; Szlachetka, Adam; Zhou, Tian et al. (2018) Pharmacokinetic testing of a first generation cabotegravir prodrug in rhesus macaques. AIDS : |
| Araínga, Mariluz; Edagwa, Benson; Mosley, R Lee et al. (2017) A mature macrophage is a principal HIV-1 cellular reservoir in humanized mice after treatment with long acting antiretroviral therapy. Retrovirology 14:17 |
| Gnanadhas, Divya Prakash; Dash, Prasanta K; Sillman, Brady et al. (2017) Autophagy facilitates macrophage depots of sustained-release nanoformulated antiretroviral drugs. J Clin Invest 127:857-873 |
Showing the most recent 10 out of 270 publications
